Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Grafton Group profit tops analyst forecasts

(Sharecast News) - Grafton Group reported an adjusted operating profit that slightly exceeded analysts' expectations on Thursday, despite a decline from the prior year.# The FTSE 250 building materials distributor and DIY retailer posted an adjusted operating profit of £177.5m, down from £205.5m in 2023.

It credited its diversified business model and operational discipline for helping it navigate challenging market conditions.

Free cash flow remained robust at £178.2m, representing a 100% conversion rate from adjusted operating profit.

Grafton maintained a strong balance sheet with £272.1m in net cash before lease liabilities, positioning the company for future growth through both organic expansion and acquisitions.

The group recently acquired Salvador Escoda, a Spanish HVAC and renewable energy distributor, for €128m, reinforcing its presence in Iberia.

It said the integration of the acquisition was progressing well.

Grafton's board increased the full-year dividend by 2.8% and approved a new £30m share buyback programme.

The company returned £154.1m to shareholders in 2024 through dividends and share repurchases, down from £228.3m the previous year.

Operationally, Ireland remained a strong performer, while the UK market continued to show signs of stabilisation.

Like-for-like daily sales growth returned in the final quarter against softer prior-year comparatives.

Overall gross margin remained steady, with tight control over overheads and a moderation in product price deflation during the second half of the year.

In addition to the announced results, Grafton confirmed the start of a new share buyback programme, with a maximum expenditure of £30m.

"We are pleased to have successfully navigated challenging market conditions in 2024 to deliver adjusted operating profit slightly ahead of analysts' expectations," said chief executive officer Eric Born.

"This resilient performance was supported by our exposure to different geographies, our diversified customer base and the active management of gross margin and costs.

"Highlights in the period included the strong performance of our Irish businesses and completion of the platform acquisition of Salvador Escoda, whilst also returning £154.1 million to shareholders through share buybacks and dividends."

Born said the integration of Salvador Escoda was continuing to progress well, extending the firm's geographic diversification and exposure to a new growth market, presenting an attractive opportunity to build further scale across the Iberian Peninsula in due course.

"Whilst the timing of recovery in certain geographies remains uncertain, the medium term outlook is positive.

"We will continue to strengthen our positions in existing markets and are excited by the development opportunities ahead."

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.